US Stock MarketDetailed Quotes

AKBA Akebia Therapeutics

Watchlist

1.3699
-0.0101-0.73%

Trading Sep 6 13:33 ET

288.07MMarket Cap-6523P/E (TTM)

Akebia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

-22.58%43.65M

-18.49%32.61M

-33.46%194.62M

0.74%56.2M

-13.69%42.05M

-55.39%56.38M

-35.16%40.01M

38.19%292.48M

-3.29%55.78M

-0.09%48.71M

Operating revenue

-22.58%43.65M

-18.49%32.61M

-33.46%194.62M

0.74%56.2M

-13.69%42.05M

-55.39%56.38M

-35.16%40.01M

38.19%292.48M

-3.29%55.78M

-0.09%48.71M

Cost of revenue

-1.37%17.05M

-42.52%11.61M

-13.34%74.15M

644.33%18.67M

-52.96%18.01M

-7.08%17.28M

-35.59%20.19M

-43.21%85.57M

-107.20%-3.43M

140.10%38.28M

Gross profit

-31.95%26.6M

5.99%21M

-41.78%120.47M

-36.61%37.53M

130.39%24.04M

-63.72%39.09M

-34.72%19.82M

239.32%206.92M

489.16%59.21M

-68.20%10.43M

Operating expense

-26.68%35.33M

-20.81%35.88M

-38.72%166.55M

-42.48%36.16M

-39.16%36.9M

-18.56%48.18M

-49.01%45.31M

-16.50%271.76M

-16.62%62.86M

-30.83%60.66M

Selling and administrative expenses

-0.44%26.92M

1.54%25.44M

-27.68%100.23M

-14.95%25.44M

-28.78%22.71M

-16.14%27.04M

-43.48%25.05M

-20.41%138.6M

-33.25%29.91M

-31.21%31.89M

Research and development costs

-62.14%7.65M

-50.57%9.73M

-51.47%63.08M

-69.27%9.87M

-52.44%13.33M

-22.40%20.2M

-55.09%19.69M

-12.08%129.99M

8.60%32.1M

-30.75%28.03M

Other operating expenses

-19.70%762K

25.18%711K

1.95%3.24M

0.47%856K

16.29%864K

6.39%949K

-17.44%568K

-9.00%3.18M

-17.20%852K

-14.60%743K

Operating profit

4.02%-8.73M

41.63%-14.88M

28.95%-46.08M

137.67%1.37M

74.38%-12.87M

-118.70%-9.09M

56.42%-25.49M

75.48%-64.85M

94.42%-3.65M

8.49%-50.23M

Net non-operating interest income expense

-30.88%-2.15M

-60.03%-2.5M

61.55%-6.03M

13.33%-1.42M

64.32%-1.41M

67.40%-1.64M

69.16%-1.56M

21.31%-15.69M

67.81%-1.64M

22.28%-3.95M

Non-operating interest expense

30.88%2.15M

60.03%2.5M

-61.55%6.03M

-13.33%1.42M

-64.32%1.41M

-67.40%1.64M

-69.16%1.56M

--15.69M

--1.64M

-22.28%3.95M

Other net income (expense)

620.91%2.29M

-446.02%-609K

101.33%182K

183.50%658K

-361.73%-212K

96.88%-440K

-84.48%176K

-667.23%-13.69M

-240.71%-788K

-81.03%81K

Gain on sale of security

--2.33M

---129K

----

Special income (charges)

--0

-442.45%-575K

95.81%-705K

--0

84.44%-169K

97.04%-430K

---106K

---16.84M

---1.22M

---1.09M

-Less：Restructuring and merger&acquisition

--0

-45.28%58K

-98.86%181K

--0

-6.11%169K

-100.65%-94K

--106K

--15.93M

--1.22M

--180K

-Less:Other special charges

----

--517K

-42.16%524K

--0

----

--524K

----

--906K

--0

--906K

Other non- operating income (expenses)

-290.00%-39K

-66.31%95K

-71.81%887K

51.61%658K

-103.68%-43K

-102.43%-10K

-75.13%282K

30.32%3.15M

-22.50%434K

173.30%1.17M

Income before tax

23.18%-8.58M

33.08%-17.99M

44.89%-51.93M

110.11%614K

73.22%-14.49M

-137.94%-11.17M

56.94%-26.88M

66.59%-94.23M

91.31%-6.07M

9.15%-54.1M

Income tax

Net income

23.18%-8.58M

33.08%-17.99M

44.89%-51.93M

110.11%614K

73.22%-14.49M

-137.94%-11.17M

56.94%-26.88M

66.59%-94.23M

91.31%-6.07M

9.15%-54.1M

Net income continuous Operations

23.18%-8.58M

33.08%-17.99M

44.89%-51.93M

110.11%614K

73.22%-14.49M

-137.94%-11.17M

56.94%-26.88M

66.59%-94.23M

91.31%-6.07M

9.15%-54.1M

Minority interest income

Net income attributable to the parent company

23.18%-8.58M

33.08%-17.99M

44.89%-51.93M

110.11%614K

73.22%-14.49M

-137.94%-11.17M

56.94%-26.88M

66.59%-94.23M

91.31%-6.07M

9.15%-54.1M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

23.18%-8.58M

33.08%-17.99M

44.89%-51.93M

110.11%614K

73.22%-14.49M

-137.94%-11.17M

56.94%-26.88M

66.59%-94.23M

91.31%-6.07M

9.15%-54.1M

Basic earnings per share

33.33%-0.04

40.00%-0.09

46.15%-0.28

108.07%0.0032

72.41%-0.08

-137.50%-0.06

57.14%-0.15

69.41%-0.52

90.00%-0.04

14.71%-0.29

Diluted earnings per share

33.33%-0.04

40.00%-0.09

46.15%-0.28

108.05%0.0032

72.41%-0.08

-140.00%-0.06

57.14%-0.15

69.41%-0.52

90.00%-0.04

14.71%-0.29

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	-22.58%43.65M	-18.49%32.61M	-33.46%194.62M	0.74%56.2M	-13.69%42.05M	-55.39%56.38M	-35.16%40.01M	38.19%292.48M	-3.29%55.78M	-0.09%48.71M
Operating revenue	-22.58%43.65M	-18.49%32.61M	-33.46%194.62M	0.74%56.2M	-13.69%42.05M	-55.39%56.38M	-35.16%40.01M	38.19%292.48M	-3.29%55.78M	-0.09%48.71M
Cost of revenue	-1.37%17.05M	-42.52%11.61M	-13.34%74.15M	644.33%18.67M	-52.96%18.01M	-7.08%17.28M	-35.59%20.19M	-43.21%85.57M	-107.20%-3.43M	140.10%38.28M
Gross profit	-31.95%26.6M	5.99%21M	-41.78%120.47M	-36.61%37.53M	130.39%24.04M	-63.72%39.09M	-34.72%19.82M	239.32%206.92M	489.16%59.21M	-68.20%10.43M
Operating expense	-26.68%35.33M	-20.81%35.88M	-38.72%166.55M	-42.48%36.16M	-39.16%36.9M	-18.56%48.18M	-49.01%45.31M	-16.50%271.76M	-16.62%62.86M	-30.83%60.66M
Selling and administrative expenses	-0.44%26.92M	1.54%25.44M	-27.68%100.23M	-14.95%25.44M	-28.78%22.71M	-16.14%27.04M	-43.48%25.05M	-20.41%138.6M	-33.25%29.91M	-31.21%31.89M
Research and development costs	-62.14%7.65M	-50.57%9.73M	-51.47%63.08M	-69.27%9.87M	-52.44%13.33M	-22.40%20.2M	-55.09%19.69M	-12.08%129.99M	8.60%32.1M	-30.75%28.03M
Other operating expenses	-19.70%762K	25.18%711K	1.95%3.24M	0.47%856K	16.29%864K	6.39%949K	-17.44%568K	-9.00%3.18M	-17.20%852K	-14.60%743K
Operating profit	4.02%-8.73M	41.63%-14.88M	28.95%-46.08M	137.67%1.37M	74.38%-12.87M	-118.70%-9.09M	56.42%-25.49M	75.48%-64.85M	94.42%-3.65M	8.49%-50.23M
Net non-operating interest income expense	-30.88%-2.15M	-60.03%-2.5M	61.55%-6.03M	13.33%-1.42M	64.32%-1.41M	67.40%-1.64M	69.16%-1.56M	21.31%-15.69M	67.81%-1.64M	22.28%-3.95M
Non-operating interest expense	30.88%2.15M	60.03%2.5M	-61.55%6.03M	-13.33%1.42M	-64.32%1.41M	-67.40%1.64M	-69.16%1.56M	--15.69M	--1.64M	-22.28%3.95M
Other net income (expense)	620.91%2.29M	-446.02%-609K	101.33%182K	183.50%658K	-361.73%-212K	96.88%-440K	-84.48%176K	-667.23%-13.69M	-240.71%-788K	-81.03%81K
Gain on sale of security	--2.33M	---129K	----	----	----	----	----	----	----	----
Special income (charges)	--0	-442.45%-575K	95.81%-705K	--0	84.44%-169K	97.04%-430K	---106K	---16.84M	---1.22M	---1.09M
-Less：Restructuring and merger&acquisition	--0	-45.28%58K	-98.86%181K	--0	-6.11%169K	-100.65%-94K	--106K	--15.93M	--1.22M	--180K
-Less:Other special charges	----	--517K	-42.16%524K	--0	----	--524K	----	--906K	--0	--906K
Other non- operating income (expenses)	-290.00%-39K	-66.31%95K	-71.81%887K	51.61%658K	-103.68%-43K	-102.43%-10K	-75.13%282K	30.32%3.15M	-22.50%434K	173.30%1.17M
Income before tax	23.18%-8.58M	33.08%-17.99M	44.89%-51.93M	110.11%614K	73.22%-14.49M	-137.94%-11.17M	56.94%-26.88M	66.59%-94.23M	91.31%-6.07M	9.15%-54.1M
Income tax
Net income	23.18%-8.58M	33.08%-17.99M	44.89%-51.93M	110.11%614K	73.22%-14.49M	-137.94%-11.17M	56.94%-26.88M	66.59%-94.23M	91.31%-6.07M	9.15%-54.1M
Net income continuous Operations	23.18%-8.58M	33.08%-17.99M	44.89%-51.93M	110.11%614K	73.22%-14.49M	-137.94%-11.17M	56.94%-26.88M	66.59%-94.23M	91.31%-6.07M	9.15%-54.1M
Minority interest income
Net income attributable to the parent company	23.18%-8.58M	33.08%-17.99M	44.89%-51.93M	110.11%614K	73.22%-14.49M	-137.94%-11.17M	56.94%-26.88M	66.59%-94.23M	91.31%-6.07M	9.15%-54.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	23.18%-8.58M	33.08%-17.99M	44.89%-51.93M	110.11%614K	73.22%-14.49M	-137.94%-11.17M	56.94%-26.88M	66.59%-94.23M	91.31%-6.07M	9.15%-54.1M
Basic earnings per share	33.33%-0.04	40.00%-0.09	46.15%-0.28	108.07%0.0032	72.41%-0.08	-137.50%-0.06	57.14%-0.15	69.41%-0.52	90.00%-0.04	14.71%-0.29
Diluted earnings per share	33.33%-0.04	40.00%-0.09	46.15%-0.28	108.05%0.0032	72.41%-0.08	-140.00%-0.06	57.14%-0.15	69.41%-0.52	90.00%-0.04	14.71%-0.29
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall